Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹8 Cr
P/E Ratio
269.83
P/B Ratio
10.52
Industry P/E
36.27
Debt to Equity
3.18
ROE
7.43 %
ROCE
1.74 %
Div. Yield
0 %
Book Value
0.78
EPS
0.03
CFO
₹-1.76 Cr
EBITDA
₹-5.49 Cr
Net Profit
₹-7.56 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Hindustan Bio Sciences
| -22.72 | 12.88 | -15.52 | -7.18 | 24.59 | 44.33 | 18.70 |
|
BSE Healthcare
| -5.78 | 2.62 | 3.66 | 20.07 | 20.57 | 22.14 | 10.31 |
|
BSE Small Cap
| -12.04 | 2.97 | -0.32 | 2.02 | 18.80 | 34.92 | 16.25 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Hindustan Bio Sciences
| 11.58 | 135.36 | -29.94 | 15.20 | 122.93 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 728.95 | 6,685.66 | 26.82 | 13.8 | |
| 1,109.30 | 8,694.07 | 71.63 | 12.96 | |
| 461.45 | 11,255.24 | 23.49 | 14.4 | |
| 886.90 | 5,090.16 | 39.95 | 14.76 |
No Review & Analysis are available.
Hindustan Bio Sciences Limited operates in pharmaceutical and biotechnology sectors in India. It offers recombinant human erythropoietin, a glycoprotein hormone that controls erythropoiesis or red blood cell production. The company also manufactures... and markets a range of finished dosage forms of pharmaceutical products, including dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, and pre-filled syringes, as well as non-sterile/sterile ointments, tablets, and capsules. In addition, it engages in the trading of drugs and medicines. The company also exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India. Read more
Incorporated
1991
Chairman
J V R Mohan Raju
Managing Director
J V R Mohan Raju
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Hindustan Bio Sciences Ltd stood at ₹ 3 Cr as on 31-Dec-24
The share price of Hindustan Bio Sciences Ltd is ₹7.89 (BSE) as of 28-Apr-2025 16:01 IST. Hindustan Bio Sciences Ltd has given a return of 24.59% in the last 3 years.
Hindustan Bio Sciences Ltd has a market capitalisation of ₹ 8 Cr as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Hindustan Bio Sciences Ltd is 10.52 times as on 28-Apr-2025, a 190% premium to its peers’ median range of 3.63 times.
The P/E ratio of Hindustan Bio Sciences Ltd is 269.83 times as on 28-Apr-2025, a 644% premium to its peers’ median range of 36.27 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Hindustan Bio Sciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Hindustan Bio Sciences Ltd.
Hindustan Bio Sciences Limited operates in pharmaceutical and biotechnology sectors in India. It offers recombinant human erythropoietin, a glycoprotein hormone that controls erythropoiesis or red blood cell production. The company also manufactures and markets a range of finished dosage forms of pharmaceutical products, including dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, and pre-filled syringes, as well as non-sterile/sterile ointments, tablets, and capsules. In addition, it engages in the trading of drugs and medicines. The company also exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.
The promoters of Hindustan Bio Sciences Ltd are VENKATA RAMA MOHAN RAJU JAMPANA and SUPER SOLUTIONS INDIA PRIVATE LIMITED. They collectively own 12.17 per cent of the total equity. The chairman of the company is J V R Mohan Raju
There is no promoter pledging in Hindustan Bio Sciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,968
|
|
|
8,743
|
|
|
6,661
|
|
|
5,068
|
| Hindustan Bio Sciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
3.78
|
|
Operating margin(%)
|
2.5
|
|
Net Margin(%)
|
3.81
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Hindustan Bio Sciences Ltd was ₹0 Cr.
₹0.10
(
